PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to ...

The American Gastroenterological Association (AGA) released a new clinical guideline making no recommendation — for or against — the use of computer-aided detection systems (CADe) in colonoscopy. A ...

Researchers have revealed another potential reason to avoid ultraprocessed foods. Seed oils — which are plant-based cooking oils that are often used in processed, packaged foods — have been linked to ...

Patients with symptoms of gastrointestinal (GI) problems and survivors of colon cancer were more likely to use oncology specialty care. Oncologic specialty care was more often used in colon cancer ...

Rising rates of early-onset colon cancer (EOCC) present challenges in deciding how to optimally treat patients. Although standard of care for stage II CC is surgical resection, adding chemotherapy for ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their ...